Wednesday, October 4, 2023
Wednesday, October 4, 2023

Contact: 561.316.3330

ExtriCARE USA Launches Innovative Medical Device Company, Offering Negative Pressure Wound Therapy Solutions

ExtriCARE USA  a national medical device company specializing in the distribution of negative pressure wound therapy (NPWT), officially announces its company launch and new user-centric website.

ExtriCARE USA, led by President Peter Mason, who has over eight years of industry experience, is fostering the future of healthcare with wound care technologies that improve patient outcomes, help clinicians with efficiency and reduce overall costs. NPWT is a modern resource still in its infancy stage. With a tailored and hands-on approach, the ExtriCARE USA team is working diligently to amplify its potential.

“I have a driving passion to develop reliable NPWT products for our network of dealers, which in turn helps patients live a better-quality life,” said Mason. “I am excited to continue building strong partnerships with dealers nationwide, allowing us to support patients and clinicians alike while reaching new heights of growth together.”

To coincide with the company’s launch, ExtriCARE USA has built a new website designed with the user in mind. The website has in-depth information on the ExtriCARE product line, the leadership team and press page with the company’s latest insights.

“With over a decade of experience in wound care, I am fortunate and proud to be a part of such a dynamic and forward-thinking team,” said Gary Schear, Vice President of Sales. “Our patient-first mentality is a driving force, and we hope to continue being a trustworthy lifeline for our providers so that they can be the lifeline for their patients.”

The ExtriCARE USA leadership team, comprised of Peter Mason, Gary Schear and Tony Cheung (Director of Operations), is committed to the future of NPWT. In partnership with Alleva Medical, the company is introducing a new product line that will transform traditional NPWT. The products are designed to be versatile, featuring state-of-the-art technology and optimized software. ExtriCARE USA and Alleva Medical will bring these portable, powerful and adaptive solutions to the market soon.

Medical Device News Magazinehttps://infomeddnews.com
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Centinel Spine’s prodisc ® Continues to Change Lives After Over 30 Years and 250,000 Total Disc Replacement Implantations

The prodisc lumbar and cervical technologies will be highlighted by Centinel Spine at the upcoming 2023 annual EUROSPINE meeting and congress in Frankfurt, Germany (October 4-6, 2023). The prodisc technology portfolio now includes four cervical and two lumbar devices—5 approved by the FDA—and has been validated with a reported reoperation rate of less than 1%.

Amber Implants Announces Start of Clinical Trial with VCFix® Spinal System

This first-in-human clinical trial will assess the safety and effectiveness of the VCFix® Spinal System implant for patients suffering from vertebral compression fractures. The implant is provided with a user-friendly, single-use sterile surgical kit, ensuring perfect traceability and reducing the risk of infection. 

RaySearch Deepens Collaboration with P-Cure

The expanded collaboration will enable users of the P-Cure proton therapy system to use RayStation and RayCare in a seamlessly integrated environment. The P-Cure system is a gantry-less seated proton system, designed to fit within linac vaults, that has recently been cleared by the FDA. It is used clinically by the Hadassah Medical Center in Jerusalem – the only proton facility in the Middle East – to treat CNS, head and neck, thoracic and pancreatic malignancies.

Edinburgh-based Med-tech Firm in MBO to Expand Into New Markets and Technologies

The acquisition will enable Novarum to build on its strong lateral flow test customer base and extend into adjacent markets. 

Biomic Sciences Issues Voluntary Nationwide Recall of ION* Sinus Support, ION* Biome Sinus, and Restore Sinus Spray Products Due to Microbial Contamination

Risk Statement: In the population most at risk, patients or individuals who recently underwent nasal or sinus surgery, there is a reasonable probability that the use of the affected product could potentially result in severe or life-threatening adverse events such as bacteremia or fungemia, invasive bacterial or fungal rhinosinusitis, or disseminated fungal infection. To date, Biomic Sciences has not received any reports of adverse events related to this product.

By using this website you agree to accept Medical Device News Magazine Privacy Policy